In this article
PeterMD advertises a tirzepatide starting payment followed by a monthly equivalent billed quarterly. It also labels the package by its total medication amount, which does not by itself establish how long it will last for an individual prescription.
A useful alternative comparison therefore checks the full payment and the clinician’s intended treatment period together. The services below use different package sizes, billing cycles, and visit models.
Confirm the initial full payment, later quarterly charge, exact product, and prescribed duration before comparing another package. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Confirm the initial full payment, later quarterly charge, exact product, and prescribed duration before comparing another package.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Confirm the initial full payment, later quarterly charge, exact product, and prescribed duration before comparing another package. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our sponsored self-pay comparison. Request a complete quote for the prescribed period so that the comparison with a quarterly offer uses the same basis.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. Fifty 410
Publishes tirzepatide package tiers with different totals. Compare the clinician-selected package, not just the cheapest tier.
Fifty 410 lists a three-month compounded tirzepatide starter package at $399 total, displayed as $133 per month. The listed mid- and higher-dose packages are $499 and $549 total. Its semaglutide monthly option is $199. These are different products and package sizes.
Ask which package matches the proposed prescription and whether a returning patient qualifies for a starter offer. A three-month supply and monthly billing are separate arrangements.
Check the official Fifty 410 program page for the current offer and conditions. Our Fifty 410 alternatives comparison examines other care models.
03. Big Easy Weight Loss
Uses 12-week packages and provides pharmacy information. Twelve weeks and three calendar months are different periods to identify on the invoice.
Big Easy shows 12-week starting packages for compounded semaglutide and tirzepatide. Its page displays starter discounts alongside regular figures: $399 versus $495 for semaglutide, and $499 versus $599 for tirzepatide. Confirm the eligible package and pharmacy before relying on a displayed price.
Twelve weeks is 84 days, not three calendar months. Compare the exact quantity, pharmacy, ingredients, and whether the new-patient discount applies to a transfer.
Check the official Big Easy Weight Loss program page for the current offer and conditions. Our Big Easy Weight Loss alternatives comparison examines other care models.
04. Emerge Weight Loss
An alternative billing cadence using four-week periods. Its dose-related price schedule requires a prescriber’s plan before a meaningful cost estimate.
Emerge’s pricing page lists $224 for a four-week starter dose, with higher listed tiers including $239, $249, and $269. It lists $279 and $289 tiers for existing patients. Dose changes require the prescriber; the price table is not a self-dosing schedule.
Emerge describes partner compounding pharmacies and a licensed-provider assessment. The general description does not identify your own pharmacy, concentration, or storage conditions. Ask for those details before your first dose.
Continue with our Emerge Weight Loss review and pricing details.
05. Maximus
Lists 28-day supplies and a longer-plan promotion. Ask for consultation charges and the full commitment to avoid comparing incomplete figures.
Maximus lists compounded semaglutide from $116 and tirzepatide from $198 per 28-day supply, alongside a first-month discount tied to a 12-month purchase. Other sections show different price ranges, so the chosen product, term, and complete clinical fees need confirmation.
Compare 28-day supplies over the same period as a calendar-month plan. Ask for the full annual obligation and consultation charges rather than assuming every displayed medication price includes the same care.
Check the official Maximus program page for the current offer and conditions. Our Maximus alternatives comparison examines other care models.
06. LifeRx.md
Describes an initial video consultation with no membership fee. Confirm the exact medication and treatment-period quote before comparing it with PeterMD’s package.
LifeRx.md advertises GLP-1 treatment from $200, no higher-dose upcharges, and no membership or subscription fees. Its asterisk says pricing, eligibility, and other terms apply; the headline does not establish every treatment’s complete price or billing period.
Ask what the starting offer covers, the prescribed period, and any testing charge. Its 24/7 customer-support statement does not establish that a prescribing clinician is available around the clock.
Check the official LifeRx.md program page for the current offer and conditions. Our LifeRx.md alternatives comparison examines other care models.
The current PeterMD baseline
PeterMD’s tirzepatide page advertises a $149 start followed by $249 per month billed quarterly. The ongoing monthly equivalent implies $747 for three months if those terms apply, but the initial full checkout amount needs confirmation.
The page describes a video consultation with a licensed physician, prescription review, and delivery if approved. It markets the offer as a 60 mg package, which is a package amount rather than a personal dosing instruction.
Confirm the exact formulation, pharmacy, total first payment, and later quarterly charge. A displayed medication quantity does not tell you how many weeks it will cover for your own prescription.
The details that decide this comparison
The advertised $249 monthly equivalent implies $747 for three months if the stated ongoing terms apply. Ask for the actual first checkout total as well as the later charge.
A package labeled 60 mg is not a personal dose or a guaranteed number of treatment weeks. The clinician and pharmacy must supply instructions for the actual prescription.
Ask whether a transfer needs a new video consultation and whether a starter offer applies. An existing prescription does not automatically carry over to a new provider.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
Save the current label, prescribed instructions, and supply dates before a transfer assessment. That gives the receiving clinician a concrete record to evaluate.
Keep other hormone or wellness purchases separate from the weight-management comparison. A product offered during checkout is not automatically a necessary part of a GLP-1 plan.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- Fifty 410: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Big Easy Weight Loss: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Emerge Weight Loss. Trusted Leader in GLP-1 Compounded Tirzepatide.Provider-published information · Checked September 21, 2026
- Tirzepatide Cost Without Insurance — From $224 | Emerge Weight LossProvider-published information · Checked September 21, 2026
- Terms & Conditions | Emerge Weight LossProvider-published information · Checked September 21, 2026
- Cancellation & Refund Policy | Emerge Weight LossProvider-published information · Checked September 21, 2026
- Maximus: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: Wegovy semaglutide tablets, NDA 218316 approval letterRegulatory source · Checked September 21, 2026
- LifeRx.md: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- PeterMD: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction